The therapeutic potential of hydrogen sulphide, especially as an anti-inflammatory drug, represents a multi-billion euro business with many clinical trials in progress. A European study is investigating the sulphide mode of action as a means of assessing its toxic health effects.
Further information: cordis.europa.eu